Prosecution Insights
Last updated: November 04, 2026

Aldexchem Kft

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Aldexchem Kft has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The company's current prosecution is concentrated under 1 distinct examiner, which simplifies the communication channel between the applicant and the USPTO. Additionally, the portfolio is active in 1 distinct art unit, suggesting that the pending claims fall within a specific pharmaceutical classification. This concentration in the art unit helps in predicting the examination timeline based on that unit's specific backlog.

The busiest examiner for the portfolio is BAKSHI, PANCHAM, who is currently handling 1 busiest examiner pending office action. This examiner manages the company's active office actions, as there is only 1 distinct examiner for the entire portfolio. The 1 pending office action represents the total current workload for the company's legal team in this jurisdiction. This focused activity allows for a precise approach to overcoming any cited rejections. With only 1 pending office action and 1 distinct art unit, the company can devote significant resources to securing this particular patent.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BAKSHI, PANCHAM 1 76.7% +30.1%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18268030 TRIARYL BORANE CATALYSTS AND METHOD FOR SELECTIVE HYDROSILYLATION OF ESTERS AND LACTONES USING SAID CATALYSTS BAKSHI, PANCHAM —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18268030 TRIARYL BORANE CATALYSTS AND METHOD FOR SELECTIVE HYDROSILYLATION OF ESTERS AND LACTONES USING SAID CATALYSTS BAKSHI, PANCHAM —

Top Art Units

Art UnitApps
1623 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18268030 TRIARYL BORANE CATALYSTS AND METHOD FOR SELECTIVE HYDROSILYLATION OF ESTERS AND LACTONES USING SAID CATALYSTS BAKSHI, PANCHAM 1623 §103§112 Final Rejection — Pending Jun 16, 2023

Managing Aldexchem Kft's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Aldexchem Kft have?

Aldexchem Kft has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Aldexchem Kft applications?

Pancham Bakshi has the most, with 1 of Aldexchem Kft's pending office actions.

What technology area are Aldexchem Kft's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month